Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This theranostics company develops monoclonal antibodies that target cancer-specific biomarkers for therapeutic and diagnostic applications. Their products aim to selectively target the causes of tumor growth, enabling personalized cancer care.